secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mosaic ImmunoEngineering Inc. (CPMV)
CIK:        0000836564
Form:       8-K
Filed at:   2023-05-03T23:59:59+00:00
Accession:  0001683168-23-002890
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director and acting Chief Scientific Officer Nicole Steinmetz resigns, will remain as scientific advisor
--------------------------------------------------------------------------------

- Nicole Steinmetz, Ph.D., resigned as director and acting CSO effective May 2, 2023.
- Resignation not due to disagreement with company on operations, policies, or practices.
- She will continue to serve as a scientific advisor to the Company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/836564/000168316823002890/0001683168-23-002890-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/836564/000168316823002890/mosaic_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-002890

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer